Page last updated: 2024-08-23

raloxifene hydrochloride and Amyotrophic Lateral Sclerosis

raloxifene hydrochloride has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, H; Hao, P; Liu, Y; Sun, C; Yan, L; Zhai, J; Zhou, F	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Amyotrophic Lateral Sclerosis

Article	Year
Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis. Brain research bulletin, 2018, Volume: 140 Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; DNA-Binding Proteins; Estrogen Replacement Therapy; Neuroprotective Agents; Peptide Fragments; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators	2018

Article

Year

Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis.

Brain research bulletin, 2018, Volume: 140

Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; DNA-Binding Proteins; Estrogen Replacement Therapy; Neuroprotective Agents; Peptide Fragments; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators

2018